MOONLAKE IMMUNOTHERAPEUTICS Cash and Cash Equivalents, Period Increase (Decrease)
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$669.13 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-17.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2022-02-17
- MOONLAKE IMMUNOTHERAPEUTICS cash and cash equivalents, period increase (decrease) for the quarter ending 2021-12-31 was -$361.96K.
- MOONLAKE IMMUNOTHERAPEUTICS cash and cash equivalents, period increase (decrease) for the quarter ending 2021-09-30 was -$68.94K.
- MOONLAKE IMMUNOTHERAPEUTICS cash and cash equivalents, period increase (decrease) for the quarter ending 2021-06-30 was -$72.37K.
- MOONLAKE IMMUNOTHERAPEUTICS cash and cash equivalents, period increase (decrease) for the quarter ending 2021-03-31 was -$165.86K.
- MOONLAKE IMMUNOTHERAPEUTICS cash and cash equivalents, period increase (decrease) for fiscal 2021 was -$669.13K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 5 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | -$361.96K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-02-17 | -$430.91K derived: sum of 2 quarters · filed 2022-02-17 | -$503.28K derived: sum of 3 quarters · filed 2022-02-17 | -$669.13K 10-K · filed 2022-02-17 | |
| 2021-09-30 | -$68.94K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2021-12-14 | -$141.31K derived: sum of 2 quarters · filed 2021-12-14 | -$307.17K 10-Q/A · filed 2021-12-14 | ||
| 2021-06-30 | -$72.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$238.23K 10-Q · filed 2021-08-16 | |||
| 2021-03-31 | -$165.86K 10-Q · filed 2021-05-21 | ||||
| 2020-12-31 | $1.34M 10-K · filed 2022-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |